chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 10Feb2023 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 64 years, in right arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 19Sep2023, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (24Sep2023) Negative, notes: By day six I tested negative for Covid; (27Sep2023) Positive, notes: I tested positive on day 9; (04Oct2023) Positive, notes: still positive on day 16; (06Oct2023) Negative, notes: before testing negative on days 18 and 20; (08Oct2023) Negative, notes: before testing negative on days 18 and 20.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.
After receiving my second vaccine I just had the normal symptoms with some mild fever and pain at the injection site. After the THIRD injection I had no symptom until 8/262021 when the lymph nodes on the right swelled up and I developed a rash around my neck. I worked as an RN my whole life and know these things happen. I have an call in to my PCP and will try to get in tomorrow. I have been taking some Benadryl OTC  and also loratidine once daily. I also have use benedryl  cream. I was just shocked it took so long for these adverse events to happen
She received the Pfizer COVID-19 Vaccine 1st dose on April 17 since then she had 9 allergic reactions which are severe and she's been back and forth to the emergency; This is a spontaneous report from a Pfizer sponsored program. A non-contactable female consumer (patient) reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 17Apr2021 (Batch/Lot number was not reported) as a single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient received the Pfizer COVID-19 Vaccine 1st dose on 17Apr2021 since then she had 9 allergic reactions which are severe and she's been back and forth to the emergency. She had medical bills that reached to thousand dollars and she was asking for compensation and she was also advised not to take the 2nd dose of the Pfizer COVID vaccine. The outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Fever between 102 and 104.4 F for 18 hours; headache; reduced appetite
This spontaneous report as received from a certified medical assistant (CMA) and refers to an unspecified number of unspecified patients of unknown age and gender. The patients' medical history and concurrent conditions were not reported. On an unknown date, the patients may have received doses of improperly stored doses of ROTATEQ, orally (L039638 expiry date: 23-AUG-2017, L046320 expiry date: 29-SEP-2017 and M019690 expiry date: 02-NOV-2017, lot reported as: L033637 expiry date: 06-JUN-2017). No adverse effect was reported. This is one of several report from the same reporter. Additional information has been requested.
Fever; coughing; This is a spontaneous report from a contactable consumer (patient).   An 83-year-old female patient received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) via an unspecified route of administration, in right arm, at single dose, on 17Feb2021, at 09:00 AM, for COVID-19 immunisation. The patient had not received any other vaccines within 4 weeks prior to the BNT162B2 vaccine.  Relevant medical history included asthma. Allergies to medications, food, or other products: penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient received other medications within 2 weeks of vaccination: blood pressure and memory medications (unspecified). On 18Feb2021, at 09:00 PM, the patient experienced fever and coughing. No treatment received. The case was assessed as non-serious (Seriousness criteria-results in death: no, seriousness criteria-life threatening: no, seriousness criteria-caused/prolonged hospitalization: no, seriousness criteria-disabling/incapacitating: no, seriousness criteria-congenital anomaly/birth defect: no). The patient did not recover from the events at time of this report. Post the vaccination, the patient has not been tested for COVID-19.  The lot number is not available despite follow-up attempts made. Follow-up attempt have been completed and no further information is expected.
eyes could not focus, they were "going around and around"; nauseous; whole body was achy; This spontaneous case was reported by a consumer and describes the occurrence of   in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
I had fatigue, sinus congestion w/o discharge,  headache on and off, chills and muscle pain. I have been getting nose bleeds.
This spontaneous report was received from a healthcare worker regarding unspecified number of patients of unknown demographics. There was no information about concurrent condition and historical medication. On an unknown date the unspecified number of patients were vaccinated with (Oka/Merck) VARIVAX exposed to -6C for 2 hours and 30 minutes, (dose strength, route and lot number was unknown). No concomitant medication was reported. No adverse event was reported. The outcome of the event was unknown. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Sensation of the vaccine running down her arm on the inside of her arm; She experienced soreness; rash near injection site; Possibly some of the vaccine may not have be injected correctly into her muscle; Wrong technique in device usage process; This case was reported by a consumer via call center representative and described the occurrence of injection site leaking in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pain (1st dose received on 5th March 2019, refer linked case US2019AMR167804).   On 21st May 2019, the patient received the 2nd dose of Shingrix (intramuscular). On 21st May 2019, less than a day after receiving Shingrix, the patient experienced injection site leaking, injection site pain, injection site rash, accidental underdose and wrong technique in device usage process. On an unknown date, the outcome of the injection site leaking, injection site pain and injection site rash were recovered/resolved and the outcome of the accidental underdose was not recovered/not resolved and the outcome of the wrong technique in device usage process was unknown.   It was unknown if the reporter considered the injection site leaking, injection site pain and injection site rash to be related to Shingrix.  Additional information received were as follows: The patient reported that she experienced a sensation of the vaccine running down her arm on the inside of her arm, no medication was visible on the outside of her arm, and believed that possibly some of the vaccine may not have be injected correctly into her muscle, which led to injection site leaking, wrong technique in device usage process and accidental underdose. The patient experienced soreness at injection site and rash near injection site. The patient planned to follow-up with her physician and pharmacy on an unknown date.  The reporter consented to follow up.
2 hrs p/vax -> loss of equilibrium when walk, fine when sitting; no change in s/s +9 days; seen by neurologist;
tachycardia; Left sided chest pain and arm pit pain; Left sided chest pain and arm pit pain; aches and soreness on the left side; Non ST segment elevation myocardial infarction; This is a spontaneous report from a contactable nurse via a Pfizer-sponsored program Support. A 56-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Apr2021 (at the age of 56-year-old; lot number: EW0175; expiry date: 31Aug2021) as DOSE 1, 0.3 ML, SINGLE for COVID-19 immunisation. Medical history included coronary artery disease, myocarditis, obesity, hyperlipidemia, smoker, depression, GERD. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) were none. Prior Vaccinations (within 4 weeks) was unknown. Events following prior vaccinations and family medical history relevant to events were none. There were no concomitant medications. Patient received the first dose on 22Apr2021, has not received the second dose yet. In Apr2021, the patient experienced non-ST segment elevation myocardial infarction. The clinical course was reported as follows: the reporting nurse noted from patient's chart stating that patient had non-ST segment elevation with myocardial infarction, which cardiology said may have been from the vaccine, and patient was referred to his physician to decide whether or not to get the 2nd dose. The reporting nurse went to speak with the patient to clarify what happened. Clarified that 4 days after receiving the 1st dose of the vaccine (on 26Apr2021), the patient started having left sided chest pain and left sided arm pit pain, as well as aches and soreness on the left side. He went to the ER on 28Apr2021, and had multiple tests done. He then went to the cardiologist and asked if this occurred from the vaccine. Clarified that the cardiologist put him on medication for his heart and said that he didn't think it was directly related to the vaccine, but suggested that the patient wait more than 6 weeks to get the 2nd dose. Events required a visit to emergency room and physician office. Lab data included testing done in the ER on 28Apr2021: EKG was normal, tachycardia; x-ray was normal, no evidence of pulmonary embolism; D-Dimer was elevated to 1.440. Treatment received for events. Outcome of events was unknown.; Sender's Comments: Based on the available information in the case, the causal association between the events, acute myocardial infarction, chest pain, axillary pain, pain and the suspect drug BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Patient stated pain, fever, and significant swelling in left arm which radiated whole arm. Physician seen 3 days post vaccine given Cephalexin for cellulitis.
6 days following vaccine I developed shingles- starting with an itchy bug bite-like bump then developing into a painful red rash with nerve pain up and down left side of body. Subsided once an antiviral treatment of Valtrex was administered.
Diarrhea, nausea, extreme fatigue, chills, fever, body aches, weakness.
Information was received from a physician regarding a 58 year old female patient. On 25SEP2012 she developed an injection site reaction following a vaccination with ZOSTAVAX. The injection site reaction was described on 26SEP2012 as red and swollen about 4 to 5 cm in diameter. The injection site reaction was still present 28SEP2012, but was about 1 cm in diameter. No other information was reported. Additional information has been requested.
about 2 days p/vax pt devel 1-2" oblong black & blue area around inj site;had extreme tenderness in lt axilla x 1 1/2wk, so tender could not apply deodorant;
allergy; Initial information was received on 09-Oct-2020 regarding an unsolicited valid non-serious social media case from a consumer or non-health care professional via social media.  This case involves an unknown demographic patient who experienced allergy (hypersensitivity), after the patient received INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), vaccination(s), family history and concomitant medication were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and other dosing details were not reported) for prophylactic vaccination.  On an unknown date, the patient developed non-serious allergy (hypersensitivity), (unknown latency) following the administration of INFLUENZA VACCINE.  The intensity of the event was severe.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome was not reported for the event.  There will be no information available on the batch number for this case.
this caused her father to start having asthma issues; felt some malaise in the following days/after the vaccine for which he has to rest a bit which subsequently caused fluid to build up in his respiratory system/ subsequent bouts of not feeling so good; This is a spontaneous report from a contactable consumer (caregiver). A 94-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 30Jan2021 (at the age of 94-years) as dose 1, single for covid-19 immunization. The patient had a history of asthma and respiratory issues, also had some bleeding issues following an aortic valve replacement that week. The patient concomitant medications included prednisone (PREDNISONE) from an unspecified start date to 21Feb2021; aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]). The reporter stated that the patient had felt some malaise in the following days after the vaccine for which he had to rest a bit which subsequently caused fluid to build up in his respiratory system. Reporter also stated that the patient stated to have asthma issues. Reporter also stated that the patient had subsequent bouts of not feeling so good. So, the patient's doctor instructed that he should wait 10 days after finishing the Prednisone before receiving his second dose. Reporter stated that today was the earliest date that she had found that he can receive his vaccine but queried to know if that was okay for him to receive that because that outside the recommended 21-day interval. Reporter was concerned about the effectiveness of the second dose being that late and did not want to have him get the second dose to get sick all over again if that was not going to protect him. Reporter stated that the patient chart showed that his second dose should have been scheduled before 29Mar2021. The outcome of the events was unknown on an unspecified date.  No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
PATIENT SCREENED FOR VACCINATIONS. MARKED "NO" TO ARE YOU PREGNANT OR PLAN ON  BECOMING PREGNANT IN THE NEXT THREE MONTHS. AFTER IMMUNIZATION WAS COMPLETED  PATIENT HAD AN APPOINTMENT FOR OVERSEAS SCREENING A PREGNANCY TEST CAME OUT POSTIVE. PATIENT WITH LMP OF 16JAN18 NEG. PREGNANCY TEST 09FEB18/13FEB18. HAD NEXPLANON PLACED 13FEB18. ON MARCH 23, 2018 NEXPLANON REMOVED.
5 mins after administering vaccine pt had difficulty breathing, chills, sweats, blurry vision, nausea, temp was 95, numbness in hands, and ringing ears. Possibly a seizure her mom said her arms were shaking a little I didn?t see anything
p/vax pt devel a mild/moderate chickenpox-like rash;pt sought medical attention;
9:00pm started with headache and body aches, by 10:00pm flu like symptoms, chills, fever, severe body aches. Lasted approx. 24 hours, took over the counter flu medication and ibuprofen.  Headache the following day with lingering fatigue.  Recovered by the 3rd day.
Chills, sore arm, fatigue and weak started 2 days after administration. Has continued > 4 days.
Immediately after needle removed donor became pale and lost consciousness. She was moved to floor, ice applied to neck. Supportive care. LOC < 1 min. Recovered quickly within 5 min. Suspect vasopressor reaction.
Got both doses of the Pfizer Covid 19 vaccine and the booster.; Her husband did pass away from end stage dementia; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A male patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunization; Bnt162b2 (Dose 2), for COVID-19 immunization. The following information was reported: IMMUNISATION (death) with onset 2021, outcome "fatal", described as "Got both doses of the Pfizer Covid 19 vaccine and the booster."; DEMENTIA (death) with onset 2021, outcome "fatal", described as "Her husband did pass away from end stage dementia". Patient was dying of end stage dementia. Consumer was taking care of him and watching him slowly die. Consumer stated her husband did pass away from end stage dementia. The patient date of death was 2021. The reported cause of death was dementia. It was not reported if an autopsy was performed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: husband did pass away from end stage dementia
This case was reported by a healthcare professional and described the occurrence of feeling sick in an adult female subject (also a nurse) who was vaccinated with (BOOSTRIX). On 26 August 2010 at 10:00 the subject received a dose of BOOSTRIX (.5 ml, unknown route, right arm). On 27 August 2010, 1 day after vaccination with BOOSTRIX, the subject experienced feeling sick, body pain, cough, headache and sweating. At the time of reporting the events were improved, but not completely resolved. Follow-up information received on 13 September 2010 indicated that the subject was 29 years old at the time of event onset and she had been diagnosed with bronchitis unrelated to the BOOSTRIX vaccine. Feeling sick, body pain, cough, headache and sweating all began on 28 August 2010. Relationship of these events to BOOSTRIX was not reported.
This spontaneous report as received from a 60 years old female consumer penicillin allergy, tetracycline allergy, morphine allergy and celiac disease reporting on herself. The patient was vaccinated with a dose of ZOSTAVAX (Lot # not reported) on 05-OCT-2012. No other co-suspects were reported. Concomitant medications included antihistamine (unspecified), SYNTHROID, PROTONA and estrogens (unspecified. The consumer reported that on 11-OCT-2012, "six days after receiving the vaccination", she started to see little itchy bumps all over her body and they were increasing. The consumer went back to the pharmacy to show the pharmacist the bumps and they said he had shingles. The patient did not receive treatment for the adverse event. There were no Lab diagnosis or studies performed. At the time of the report, the patient had not recovered. Additional information has been requested.
Patient experienced redness and a raised bump on her arm at injection site. Expressed concern over the pain.
Fever 101, evening of vaccine. Then redness, swellling and pain left deltoid - wife said 3"x4" in diameter. Pt has maintained fever of 100-101.0 since last with PCP. Fever for 3 days although not febrile at follow-up visit.
I got the vaccine on 4/7/21 at approx. 10am. Soreness at injection site started about an hour later. At approx. 3pm that day I began to have body aches and chills and had a low grade fever and a very bad and continuous headache. Those symptoms lasted approx. 24-36 hours. By Friday 4/9, I was feeling better and fever was gone. Starting approx. Sun 4/11 I began to have a dull headache wrapping around the back of my head/neck and began having muffled hearing (bilateral, but more prominent in left ear). On 4/15 at approx. 1:15pm I was sitting at my desk and suddenly my heart rate went from resting heart rate to 150. I could feel the pounding in my head and ear and also placing my hand over my heart. I tried to stand up to walk around thinking that might help my heart rate, but I felt faint, so I immediately drove myself to urgent care. My heart rate came down and was back to normal approx. 5-10 min from onset. EKG and CT were done in the ER. I was released approx. 5-6 hours after arrival and told to treat headache with Tylenol or Ibuprofen (which I have not done so far because I normally try not to take medications), and follow up with my primary doctor in a week. Headache and muffled hearing are still present today (4/17), predominately affecting left ear.
Aches from bones; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Aches from bones) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced BONE PAIN (Aches from bones). At the time of the report, BONE PAIN (Aches from bones) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was asking whether she can take ibuprofen or not.  No concomitant medication information was provided. No treatment medication were provided.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow up received on 05-Aug-2021 and contains no new information.
Red raised rash on face around eyes on forehead on arms and hands and itchy. Band-aid removed and Benadryl 1 1/2 tsp po given. Rash slowly begun to fade.
First muscle cramp escalates to impairment use of hands, arms and legs. Extremely difficult to walk, dress, unable to lay on either site. Treated with Tylenol, deep heat, chiropractor. Currently taking Cipro antibiotics and PrioGenetics Quarter Body Tent.
R21 - Rash N17.9 - AKI (acute kidney injury)  Z86.79 - H/O CHF
Aside from heavy/ sore arm low grade fever and change in appetite, I experienced post menstruated bleeding around the 10th of September until currently. I am also on birth control, this bleeding has been daily and enough to change a panty liner with every time I use the rest room.
Information has been received from a pharmacist concerning a 40 year-old patient with a history of recurrent shingles, who, on an unspecified date, was vaccinated with a dose of ZOSTAVAX. No adverse effects were reported. Additional information has been requested.
Pt developed flu like symptoms characterized by muscle weakness, scratchy sore throat, slight fever and green mucus. Pt recovered.